Idiopathic pulmonary fibrosis vs. pulmonary involvement of collagen vascular disease:HRCT findings.
10.3348/jkrs.1993.29.6.1208
- Author:
Myung Kwan LIM
;
Jung Gi IM
;
Joong Mo AHN
;
Ji Hye KIM
;
Seon Kyu LEE
- Publication Type:Original Article
- MeSH:
Collagen*;
Female;
Fibrosis;
Humans;
Idiopathic Pulmonary Fibrosis*;
Lung;
Lung Diseases, Interstitial;
Lymph Nodes;
Male;
Pleural Effusion;
Pulmonary Fibrosis
- From:Journal of the Korean Radiological Society
1993;29(6):1208-1213
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Both idiopathic pulmonary fibrosis (IPF) and pulmonary involvement of collagen vascular disease(CVD) are well known cause of diffuse interstitial lung disease which lead to fibrosis and honeycombing. We analyzed HRCT findings of 33 patients with IPF and 14 patients with CVD in terms of predominant pattern, site of involvement, mediastinal lymph node enlargement, pleural change and pulmonary volume loss. Criteria of mediastinal lymph node enlargement and pleural thickening were 15mm in long diameter and 3mm, respectively. Volume loss of the lung was measured by using hilar height ratio (apex to hilum/hilum to diaphragmatic dome). Mean age was 61 years for IPF and 46 years for CVD and male: female ratio was 27:6, 4:10, respectively. Predominant HRCT pattern was honeycombing for IPF (63%), and ground-glass opacity for CVD (66%) (p=0.001). Predominantly, subpleural involvement was seen in 90% for IPF and 74% for CVD. Mediastinal lymph node enlargement was seen in 47% of the patient with IPF and 14% with CVD (p=0.004). pleural thickening was seen in 97% of the patients with IPF and 42% with CVD (P=0.002), Pleural effusion was seen in 10% of the patients with IPF and 36% with CVD (P=0.009). Hilar height ratio of more than 1.5 was seen in 84% of the patients with IPF and 29% with CVD. In conclusion, our study shows that patients with IPF are prone to have more progressed stage of pulmonary fibrosis than the patients with CVD on HRCT.
